MRK
What one share of Merck & Co. holds
Pharmaceutical Preparations
Merck & Co., Inc. (Merck or the Company) is a global health care company that delivers innovative health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company’s operations are principally managed on a product basis and include two operating segments, Pharmaceutical and Animal Health, both of which are reportable segments.
Merck & Co.’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $26.83 |
|---|---|
| Profit | $1.28 |
| Capex (buildings and equipment) | $1.57 |
| Free cash flow | $6.47 |
| Dividends | $3.36 |
| Cash and investments | $3.39 |
| Debt | $21.85 |
| Book value | $17.00 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $14.28 | $1.41 | $0.58 | $3.14 | $1.85 | $14.60 |
| 2017 | $14.60 | $0.87 | $0.69 | $1.66 | $1.89 | $12.73 |
| 2018 | $15.79 | $2.32 | $0.98 | $3.10 | $1.99 | $10.34 |
| 2019 | $15.16 | $3.82 | $1.31 | $3.90 | $2.26 | $10.21 |
| 2020 | $16.34 | $2.78 | $1.74 | $2.29 | $2.48 | $10.01 |
| 2021 | $19.19 | $5.14 | $1.75 | $3.42 | $2.64 | $15.11 |
| 2022 | $23.32 | $5.71 | $1.73 | $5.79 | $2.80 | $18.12 |
| 2023 | $23.60 | $0.14 | $1.52 | $3.59 | $2.96 | $14.84 |
| 2024 | $25.25 | $6.74 | $1.33 | $7.12 | $3.12 | $18.33 |
| 2025 | $25.93 | $7.28 | $1.64 | $4.93 | $3.28 | $21.28 |